Ghent University Academic Bibliography

Show Sort by

Your filters: cql: keyword exact "positron emission tomography"

Mark
- conference
- C3
- open access
Validation of different static [18F]FET-PET parameters in the discrimination of low- and high-grade gliomas

Michaël Henrotte, Stijn Bonte (UGent) , Giorgio Hallaert (UGent) , Jean-Pierre Kalala Okito (UGent) and Ingeborg Goethals (UGent)

(2018) 7th European conference on clinical neuroimaging : final program. p.52-52
Mark
- dissertation
Xylem and phloem functioning of Populus tremula trees under drought, and elevated CO2 concentration and temperature

Michiel Hubeau (UGent)

(2018)
Mark
PET and MRI guided irradiation of a glioblastoma rat model using a micro-irradiator

Julie Bolcaen (UGent) , Benedicte Descamps (UGent) , Tom Boterberg (UGent) , Christian Vanhove (UGent) and Ingeborg Goethals (UGent)

(2017) JOVE-JOURNAL OF VISUALIZED EXPERIMENTS.
Mark
- conference
- C3
18F-FDG uptake in the healthy brain as a function of age and start of acquisition

Elin Pauwels (UGent) , Stijn Bonte (UGent) , Andre Dobbeleir, Stijn Verleden (UGent) , Kurt Audenaert (UGent) , Roel Van Holen (UGent) and Ingeborg Goethals (UGent)

(2016) EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 43(suppl. 1). p.S253-S253
Mark
- dissertation
Development of digital silicon photomultipliers based detectors for high-resolution positron emission tomography

Radoslaw Marcinkowski (UGent)

(2016)
Mark
Current use of imaging and electromagnetic source localization procedures in epilepsy surgery centers across Europe

Brian E Mouthaan, Matea Rados, Péter Barsi, Paul Boon (UGent) , David W Carmichael, Evelien Carrette (UGent) , Dana Craiu, J Helen Cross, Beate Diehl, Petia Dimova, et al.

(2016) EPILEPSIA. 57(5). p.770-776
Mark
Nuclear medicine for the investigation of canine behavioral disorders

Olivia Taylor, Kurt Audenaert (UGent) , Chris Baeken (UGent) , Jimmy Saunders (UGent) and Kathelijne Peremans (UGent)

(2016) JOURNAL OF VETERINARY BEHAVIOR-CLINICAL APPLICATIONS AND RESEARCH. 16. p.94-103
Mark
µPET imaging of the pharmacokinetic behavior of medium and high molar mass 89Zr-labeled poly(2-ethyl-2-oxazoline) in comparison to poly(ethylene glycol)

Leonie Wyffels, Thomas Verbrugghen, Bryn Monnery (UGent) , Mathias Glassner (UGent) , Sigrid Stroobants, Richard Hoogenboom (UGent) and Steven Staelens

(2016) JOURNAL OF CONTROLLED RELEASE. 235. p.63-71
Mark
Effect of local TOF Kernel miscalibrations on contrast-noise in TOF PET

Enrico Clementel (UGent) , Pieter Mollet (UGent) and Stefaan Vandenberghe (UGent)

(2013) IEEE TRANSACTIONS ON NUCLEAR SCIENCE. 60(3). p.1578-1588
Mark
Improved HPLC purification strategy for [11C]raclopride and [11C]DASB leading to high radiochemical yields and more practical high quality radiopharmaceutical formulations

Nick Van Laeken (UGent) , Ken Kersemans (UGent) , Dieter De Meestere, Ingeborg Goethals (UGent) and Filip De Vos (UGent)

(2013) APPLIED RADIATION AND ISOTOPES. 78. p.62-67

Academic Bibliography

Validation of different static [18F]FET-PET parameters in the discrimination of low- and high-grade gliomas

Xylem and phloem functioning of Populus tremula trees under drought, and elevated CO2 concentration and temperature

PET and MRI guided irradiation of a glioblastoma rat model using a micro-irradiator

18F-FDG uptake in the healthy brain as a function of age and start of acquisition

Development of digital silicon photomultipliers based detectors for high-resolution positron emission tomography

Current use of imaging and electromagnetic source localization procedures in epilepsy surgery centers across Europe

Nuclear medicine for the investigation of canine behavioral disorders

µPET imaging of the pharmacokinetic behavior of medium and high molar mass 89Zr-labeled poly(2-ethyl-2-oxazoline) in comparison to poly(ethylene glycol)

Effect of local TOF Kernel miscalibrations on contrast-noise in TOF PET

Improved HPLC purification strategy for [11C]raclopride and [11C]DASB leading to high radiochemical yields and more practical high quality radiopharmaceutical formulations

Contents

Support

Contact